Summary
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as tariffs roil the stock market.
Source: USA TODAY
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
